IDMA supports patent waiver for vaccines to ramp up production
Urges global pharma companies to grant voluntary licenses (VL) and transfer technology of vaccines to Indian companies against…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
IDMA
There should be a change in SOP parameters for evaluating FDCs: Dr RK Sanghavi
A sub-committee of DTAB has asked manufacturers of FDCs which were considered irrational by Prof Kokate Committee to present their…
Industry welcomes PLI 2.0 Scheme, awaits implementation details
Stakeholders highlight that this scheme will help play to our strengths, work towards making the pharma industry more…
MoEF amendment brings APIs and intermediates under single category
This move provides flexibility to the industry to change the raw material mix/or product mix within the sanctioned pollution load
DCGI calls for suggestions from industry to reduce compliance burden
Pharma associations are likely to submit their recommendations by early next month
Industry stakeholders raise concerns about price increase of PVC granules
The industry has indicated that it will suspend production of few products till the time price gets streamlined
Include pharma workforce in priority list for COVID-19 vaccination: Pharma associations
The proposed move will benefit over two million workforce and ensure uninterrupted supply of medicines in the country, say…
Minister of Chemicals and Fertilisers encourages industry to avail Phase II PLI scheme benefits
The scheme will be designed to benefit MSMEs along with large players
India has key role to play in equitable distribution of COVID-19 vaccines: Industry experts
Experts bat for global cooperation and coordination to tackle COVID-19 pandemic
Pharma industry urges government to extend MEIS scheme till March 2021
Since April 2020, the Indian pharma industry is facing a challenge in availing the MEIS benefits